Narayana Hrudayalaya Ltd's Q3FY25 Quarter Results
- 15 Feb 2025
Result Summary
- Narayana Hrudayalaya Ltd reported a 2.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 13.4%.
- Its expenses for the quarter were down by 2.1% QoQ and up 15.1% YoY.
- The net profit decreased 2.9% QoQ and increased 2.6% YoY.
- The earnings per share (EPS) of Narayana Hrudayalaya Ltd stood at 9.5 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 1385.04 | 1423.61 | 1221.52 | -2.7% | 13.4% |
Total Expenses | 1166.22 | 1191.84 | 1012.94 | -2.1% | 15.1% |
Profit Before Tax | 218.82 | 231.77 | 208.58 | -5.6% | 4.9% |
Tax | 25.76 | 32.98 | 20.48 | -21.9% | 25.8% |
Profit After Tax | 193.06 | 198.79 | 188.11 | -2.9% | 2.6% |
Earnings Per Share | 9.50 | 9.80 | 9.30 | -3.1% | 2.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Narayana Hrudayalaya Ltd is a prominent player in the healthcare industry, primarily focused on providing affordable healthcare services with a network of hospitals across India. The company is renowned for its specialized services in cardiac care, oncology, neurology, orthopedics, and other medical fields. As of the latest information, Narayana Hrudayalaya has continued to expand its operations, incorporating advanced technology to enhance patient care and operational efficiency. The company's mission revolves around delivering high-quality healthcare services to a broader spectrum of patients, including those in economically weaker sections. Any recent major developments in the company are not available from the provided data, but the company has a history of strategic expansions and partnerships aimed at increasing its service footprint.
Revenue
In Q3FY25, Narayana Hrudayalaya Ltd reported a total income of ₹1385.04 crores, reflecting a decrease of 2.7% from the previous quarter, Q2FY25, where the total income was ₹1423.61 crores. However, when compared to the same quarter in the previous fiscal year, Q3FY24, there was a notable increase of 13.4% from ₹1221.52 crores. This year-over-year growth suggests a strong upward trajectory in revenue generation over the past year, despite a slight decline in the quarterly comparison. The company's ability to sustain such revenue growth annually could be indicative of its effective business strategies and market position within the healthcare sector.
Profitability
The profitability metrics for Narayana Hrudayalaya Ltd show a mixed performance in Q3FY25. The profit before tax stood at ₹218.82 crores, which is a 5.6% decline from ₹231.77 crores reported in Q2FY25. Despite this quarter-over-quarter decrease, there is a year-over-year increase of 4.9% compared to the profit before tax of ₹208.58 crores in Q3FY24. The tax expense for Q3FY25 was ₹25.76 crores, down 21.9% from the previous quarter, and up 25.8% from the same quarter last year. Consequently, the profit after tax amounted to ₹193.06 crores, down by 2.9% quarter-over-quarter but up by 2.6% year-over-year. The earnings per share (EPS) in Q3FY25 were ₹9.50, a decrease of 3.1% from Q2FY25 but an increase of 2.2% from Q3FY24. This data indicates fluctuating profit margins with a general upward trend when compared on an annual basis.
Operating Metrics
The company's operating expenses in Q3FY25 were ₹1166.22 crores, reflecting a 2.1% decrease from ₹1191.84 crores in Q2FY25. Compared to Q3FY24, there was an increase of 15.1% from ₹1012.94 crores. This year-over-year rise in expenses indicates potentially increased operational activities and expansions, aligning with the reported increase in total income. The operational efficiency can also be assessed through the profit before tax margin, which saw a slight decrease on a quarterly basis but an increase annually, suggesting a consistent ability to manage expenses relative to income growth. The company's operational metrics reveal a strategic approach to balancing expenditure with income growth, while maintaining profitability in a competitive healthcare industry.
